Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated

Xi Jin1, Jianguo Gao1, Ruoheng Zheng2

  • 1Department of Gastroenterology, the First Affiliated Hospital, School of Medicine, Zhejiang University, 310003, Hangzhou, China.

Cell Death & Disease
|February 15, 2020
PubMed

Insights

Circular RNA_002581 plays a role in nonalcoholic steatohepatitis (NASH) by suppressing autophagy. Targeting this circular RNA may offer a therapeutic strategy for NASH by restoring autophagy.

Area of Science:

  • Hepatology and Molecular Biology
  • Cellular and Molecular Pathology
  • RNA Biology

Background:

  • Circular RNAs (circRNAs) are implicated in various diseases, but their role in nonalcoholic steatohepatitis (NASH) is largely unknown.
  • NASH pathogenesis involves complex molecular pathways including lipid accumulation, inflammation, and cell death.

Purpose of the Study:

  • To investigate the function of circRNA_002581 in NASH development.
  • To elucidate the molecular mechanisms underlying circRNA_002581's role in NASH.
  • To explore circRNA_002581 as a potential therapeutic target for NASH.

Main Methods:

  • In vitro and in vivo models of NASH were established using free fatty acids and a methionine-choline-deficient (MCD) diet.
  • RNA immunoprecipitation, RNA-Fluorescence In Situ Hybridization, and dual luciferase assays confirmed the circRNA_002581-miR-122-CPEB1 axis.
  • Western blot analysis assessed autophagy flux and the PTEN-AMPK-mTOR pathway.

Main Results:

  • CircRNA_002581 knockdown attenuated NASH phenotypes, reducing lipid accumulation, liver enzymes (ALT, AST), inflammation, apoptosis, and oxidative stress.
  • CircRNA_002581 knockdown restored autophagy flux, evidenced by increased autophagosome formation and altered LC3-II/I and p62 levels.
  • The protective effects were linked to the CPEB1-PTEN-AMPK-mTOR pathway and autophagy restoration.

Conclusions:

  • The circRNA_002581-miR-122-CPEB1 axis contributes to NASH pathogenesis by suppressing autophagy via the PTEN-AMPK-mTOR pathway.
  • Targeting circRNA_002581 represents a promising therapeutic strategy for NASH by partially restoring autophagy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K